Health burden and economic impact of measles-related hospitalizations in Italy in 2002-2003

Filia, Antonietta; Brenna, Antonio; Panà, Augusto; Cavallaro, Gianluca Maggio; Massari, Marco; Ciofi degli Atti, Marta L.
January 2007
BMC Public Health;2007, Vol. 7, p1
Academic Journal
Background: A large measles outbreak occurred in Italy in 2002-2003. This study evaluates the health burden and economic impact of measles-related hospitalizations in Italy during the specified period. Methods: Hospital discharge abstract data for measles hospitalizations in Italy during 2002-2003 were analysed to obtain information regarding number and rates of measles hospitalizations by geographical area and age group, length of hospital stay, and complications. Hospitalization costs were estimated on the basis of Diagnosis-Related Groups. Results: A total of 5,154 hospitalizations were identified, 3,478 (67%) of which occurred in children <15 years of age. Most hospitalizations occurred in southern Italy (71 %) and children below 1 year of age presented the greatest hospitalization rates (46.2/100,000 and 19.0/100,000, respectively in 2002 and 2003). Pneumonia was diagnosed in 594 cases (11.5%) and encephalitis in 138 cases (2.7%). Total hospital charges were approximately € 8.8 million. Conclusion: The nationwide health burden associated with measles during the 2002-2003 outbreak was substantial and a high cost was incurred by the Italian National Health Service for the thousands of measles-related hospitalizations which occurred. By assuming that hospital costs represent 40-50% of the direct costs of measles cases, direct costs of measles for the two years combined were estimated to be between €17.6 - 22.0 million, which equates to the vaccination of 1.5-1.9 million children (3-4 birth cohorts) with one dose of MMR. The high cost of measles and the severity of its complications fully justify the commitment required to reach measles elimination.


Related Articles

  • Incidence, mortality and economic consequences.  // Thorax;Dec2001 Supplement 4, Vol. 56, piv13 

    The article focuses on the incidence, mortality and economic consequences of community acquired pneumonia (CAP). The annual incidence in the community is 5-11 per 1000 adult population. CAP accounts for 5-12% of all cases of adult lower respiratory tract infection managed by general...

  • Childhood CAP a significant QOL and economic burden to families.  // PharmacoEconomics & Outcomes News;7/16/2005, Issue 482, p8 

    Discusses research being done on the economic and quality of life burden posed by community-acquired pneumonia (CAP) among children to parents. Reference to a study by Y. Shoham et al published in a May 2005 issue of "Pediatrics"; Costs and days lost by working mothers for the control of CAP...

  • Optimal vaccination to prevent pneumococcal disease? Plosker, Greg // PharmacoEconomics & Outcomes News;11/24/2012, Issue 667, p5 

    The article focuses on several studies related to 13-valent pneumococcal conjugate vaccine (PCV13) for invasive pneumococcal disease (IPD). Researchers in Malaysia have found that the said vaccine can lessen the burden of the disease. Studies in Brazil also show the potential of PCV13 compared...

  • Healthcare-related measles outbreak "costly and disruptive.".  // PharmacoEconomics & Outcomes News;5/28/2011, Issue 629, p5 

    The article discusses research on the outbreak-response costs of health care-related measles for hospitals in the U.S., referencing a study by S. Y. Chen and colleagues published in the "Journal of Infectious Diseases."

  • Cost-Effective Approaches to the Treatment of Community-Acquired Pneumonia in the Era of Resistance. Kuti, J.L.; Capitano, B.; Nicolau, D.P. // PharmacoEconomics;2002, Vol. 20 Issue 8, p513 

    Community-acquired pneumonia (CAP) infects upwards of four million people in the US each year, of which 20% require subsequent hospitalisation. Consequently, it is a large contributor to excessive healthcare resource consumption and cost. Since the aetiology of CAP is not identified in a...

  • CNE/CME questions.  // Hospital Infection Control & Prevention;May2009, Vol. 36 Issue 5, p59 

    A quiz on health care topics covered in the issue, including carbapenem-resistant Klebsiella pneumoniae and health care costs, is presented.

  • OPINION.  // Corridor Business Journal;3/4/2013, Vol. 9 Issue 31, p17 

    In the article authors reflects their thoughts on the negative and positive socio-economic impacts on the Linn County, Iowa.

  • The average cost of measles cases and adverse events following vaccination in industrialised countries. Carabin, Hélène; Edmunds, W. John; Kou, Ulla; Van den Hof, Susan; Van Hung Nguyen // BMC Public Health;2002, Vol. 2, p22 

    Background: Even though the annual incidence rate of measles has dramatically decreased in industrialised countries since the implementation of universal immunisation programmes, cases continue to occur in countries where endemic measles transmission has been interrupted and in countries where...

  • News and Notes.  // British Medical Journal (Clinical Research Edition);6/14/1986, Vol. 292 Issue 6535, p1604 

    Reports medical issues happening around the world. Recalculation on the effects of radiation on the bomb victims of Hiroshima bombing in Hiroshima, Japan; Statistics of United States citizens unable to afford medical care; Epidemic of measles in Canada.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics